R
Robin Vann
Researcher at Duke University
Publications - 15
Citations - 506
Robin Vann is an academic researcher from Duke University. The author has contributed to research in topics: Optical coherence tomography & Trabecular meshwork. The author has an hindex of 9, co-authored 14 publications receiving 421 citations. Previous affiliations of Robin Vann include Durham University & Bascom Palmer Eye Institute.
Papers
More filters
Journal ArticleDOI
Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia
Robin Vann,Carol L. Karp +1 more
TL;DR: In this article, the authors evaluated the role of combined subconjunctival and topical interferon alfa-2b (IFNα2b) in the treatment of conjunctival/perilesional intraepithelial neoplasia (CIN).
Journal Article
Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.
Pratap Challa,Silke Schmidt,Yutao Liu,Xuejun Qin,Robin Vann,Pedro Gonzalez,R. Rand Allingham,Michael A. Hauser +7 more
TL;DR: An analysis of LOXL1 and XFG in a United States patient population and has confirmed the strong association previously reported for Icelandic and Swedish samples, however, due to the high frequency of risk alleles in non-XFG individuals, this association should not form the basis of a diagnostic test for XFG.
Journal ArticleDOI
Preclinical evaluation and intraoperative human retinal imaging with a high-resolution microscope-integrated spectral domain optical coherence tomography device.
Paul Hahn,Justin V Migacz,Rachelle V. O'Connell,Shelley Day,Annie Lee,Phoebe Lin,Robin Vann,Anthony N. Kuo,Sharon Fekrat,Prithvi Mruthyunjaya,Eric A. Postel,Joseph A. Izatt,Cynthia A. Toth +12 more
TL;DR: High-resolution MIOCT imaging using the prototype device in human eyes during vitreoretinal surgery, with successful achievement of predefined end points for imaging is described.
Journal ArticleDOI
Autotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressure.
TL;DR: Observations indicate that the ATX-LPA axis represents a potential therapeutic target for lowering IOP in glaucoma patients.
Journal ArticleDOI
Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity.
Leona Ho,Anja Osterwald,Iris Ruf,Daniel Hunziker,Patrizio Mattei,Pratap Challa,Robin Vann,Christoph Ullmer,Ponugoti Vasanth Rao +8 more
TL;DR: A significant increase in the levels of autotaxin, lysophosphatidylcholine (LPC), LPA and connective tissue growth factor (CTGF) in the AH of Caucasian and African American open angle glaucoma patients relative to age-matched non-glaucomA patients is reported.